← Leaderboards
Paul E. M. Phillips
University Of Washington
$15,934,032
Attributed
$18,330,042
Total exposure
17
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,330,042 · 17
By mechanism
R01$7,363,992 · 6
T32$3,765,721 · 1
R37$2,517,481 · 1
P50$1,518,063 · 1
R25$1,356,870 · 1
R21$1,086,457 · 3
Top collaborators
- Susan Marie Ferguson6 shared
- Matthijs Verhage4 shared
- Howard L Fields3 shared
- P Read Montague2 shared
- Antonello Bonci1 shared
Most similar at University Of Washington
Same institution · by research overlap
- Donald K Perovich$7,739,833
- Eric J Steig$8,427,823
- Edwin D Waddington$3,556,017
- Stephen G Warren$3,163,401
- Bonnie Light$3,597,428
Others in their field
Top investigators on “Dopamine”
- Pedro A. Jose · George Washington University$34,248,029
- Jonathan A Javitch · Columbia University Health Sciences$28,566,988
- Michael A Nader · Emory University$26,344,520
- Dalton James Surmeier · University Of Tennessee Health Sci Ctr$23,527,588
- Michael A Schwarzschild · Massachusetts General Hospital$22,973,787
- David Sulzer · Columbia University Health Sciences$22,837,505
Research focus
DopamineSignal TransductionAnimalsNucleus AccumbensResponseBehaviorBehavioralTransmission ProcessScanningStimulusRattusDopaminergic NeuronRewardsAddictionTrainingDecision MakingNeuronsMonitorPharmaceutical PreparationsInsightResolutionNeurochemistryNeurobiologyDrug Usage
Grant awards (59)
Training in Addiction Neuroscience$653,048
T32 · FY2025 · DA · contact PI
University of Washington Significant Opportunities in Addiction Research (UW-SOAR) Neuroscience Doctoral Readiness Program$232,620
R25 · FY2025 · DA
Training in Addiction Neuroscience$669,901
T32 · FY2024 · DA · contact PI
University of Washington Significant Opportunities in Addiction Research (UW-SOAR) Neuroscience Doctoral Readiness Program$445,812
R25 · FY2024 · DA
Neural mechanisms regulating cocaine consumption$444,355
R37 · FY2024 · DA · contact PI
Neural mechanisms regulating cocaine consumption$519,681
R37 · FY2023 · DA · contact PI
Training in Molecular Pharmacology of Abused Drugs$516,414
T32 · FY2023 · DA · contact PI
University of Washington Significant Opportunities in Addiction Research (UW-SOAR) Neuroscience Doctoral Readiness Program$445,812
R25 · FY2023 · DA
Neural mechanisms regulating cocaine consumption$519,681
R37 · FY2022 · DA · contact PI
Training in Molecular Pharmacology of Abused Drugs$504,059
T32 · FY2022 · DA · contact PI
University of Washington Significant Opportunities in Addiction Research (UW-SOAR) Neuroscience Doctoral Readiness Program$232,626
R25 · FY2022 · DA
Neural mechanisms regulating cocaine consumption$516,882
R37 · FY2021 · DA · contact PI
Training in Molecular Pharmacology of Abused Drugs$493,390
T32 · FY2021 · DA · contact PI
Neural mechanisms regulating cocaine consumption$516,882
R37 · FY2020 · DA · contact PI
Training in Molecular Pharmacology of Abused Drugs$478,149
T32 · FY2020 · DA · contact PI
Training in Molecular Pharmacology of Abused Drugs$450,760
T32 · FY2019 · DA · contact PI
Diametric changes in phasic dopamine to contingent and non-contingent drug cues in the regulation of drug taking and drug seeking$339,900
R01 · FY2019 · DA · contact PI
Dopamine/CRF interactions in the genesis of depressive disorders.$311,242
P50 · FY2019 · MH · contact PI
8/8 NADIA UO1 Adolescent Alcohol and Decision Making$173,813
U01 · FY2019 · AA · contact PI
Diametric changes in phasic dopamine to contingent and non-contingent drug cues in the regulation of drug taking and drug seeking$339,900
R01 · FY2018 · DA · contact PI
Dopamine/CRF interactions in the genesis of depressive disorders.$311,242
P50 · FY2018 · MH · contact PI
8/8 NADIA UO1 Adolescent Alcohol and Decision Making$173,813
U01 · FY2018 · AA · contact PI
Diametric changes in phasic dopamine to contingent and non-contingent drug cues in the regulation of drug taking and drug seeking$339,900
R01 · FY2017 · DA · contact PI
Dopamine/CRF interactions in the genesis of depressive disorders.$311,242
P50 · FY2017 · MH · contact PI
Neural Mechanisms of Risk Preference Following Adolescent Alcohol Exposure$309,000
R01 · FY2017 · AA · contact PI
8/8 NADIA UO1 Adolescent Alcohol and Decision Making$173,813
U01 · FY2017 · AA · contact PI
Diametric changes in phasic dopamine to contingent and non-contingent drug cues in the regulation of drug taking and drug seeking$336,501
R01 · FY2016 · DA · contact PI
Dopamine/CRF interactions in the genesis of depressive disorders.$311,242
P50 · FY2016 · MH · contact PI
Diametric changes in phasic dopamine to contingent and non-contingent drug cues in the regulation of drug taking and drug seeking$339,900
R01 · FY2015 · DA · contact PI
Dopamine/CRF interactions in the genesis of depressive disorders.$273,095
P50 · FY2015 · MH · contact PI
2015 Catecholamines Gordon Research Conference$25,000
R13 · FY2015 · DA · contact PI
Contribution of dopamine to risk attitude across the lifespan$351,488
R01 · FY2014 · AG · contact PI
Contribution of dopamine to risk attitude across the lifespan$340,943
R01 · FY2013 · AG · contact PI
Spatiotemporal dynamics of striatal dopamine release in reinforcement learning$287,630
R01 · FY2013 · DA · contact PI
2013 Catecholamines Gordon Research Conference and Gordon Research Seminar$25,200
R13 · FY2013 · DA · contact PI
Contribution of dopamine to risk attitude across the lifespan$343,376
R01 · FY2012 · AG · contact PI
CRF Modulation of NMDA Currents and Behavior in the VTA$319,625
R01 · FY2012 · DA
Spatiotemporal dynamics of striatal dopamine release in reinforcement learning$299,614
R01 · FY2012 · DA · contact PI
CRF Modulation of NMDA Currents and Behavior in the VTA$321,453
R01 · FY2011 · DA
Spatiotemporal dynamics of striatal dopamine release in reinforcement learning$299,614
R01 · FY2011 · DA · contact PI
Subsecond modulation of cost/benefit decision making by dopamine$295,367
R01 · FY2011 · MH · contact PI
CRF Modulation of NMDA Currents and Behavior in the VTA$333,279
R01 · FY2010 · DA
Spatiotemporal dynamics of striatal dopamine release in reinforcement learning$308,880
R01 · FY2010 · DA · contact PI
Subsecond modulation of cost/benefit decision making by dopamine$298,350
R01 · FY2010 · MH · contact PI
CRF Modulation of NMDA Currents and Behavior in the VTA$369,972
R01 · FY2009 · DA
Subsecond modulation of cost/benefit decision making by dopamine$298,350
R01 · FY2009 · MH · contact PI
Spatiotemporal dynamics of striatal dopamine release in reinforcement learning$273,000
R01 · FY2009 · DA · contact PI
Dopaminergic modulation of cost/benefit decision making during aging$91,234
R21 · FY2009 · AG · contact PI
Subsecond modulation of cost/benefit decision making by dopamine$298,350
R01 · FY2008 · MH · contact PI
Subsecond dopamine release during compulsive drug taking$191,100
R21 · FY2008 · DA · contact PI
Dopaminergic activity and release during DBS implantation in humans$151,646
R21 · FY2008 · DA
Dopaminergic modulation of cost/benefit decision making during aging$91,710
R21 · FY2008 · AG · contact PI
Subsecond modulation of cost/benefit decision making by dopamine$319,600
R01 · FY2007 · MH · contact PI
Subsecond dopamine release during compulsive drug taking$219,947
R21 · FY2007 · DA · contact PI
Dopaminergic activity and release during DBS implantation in humans$168,116
R21 · FY2007 · DA
Dopaminergic modulation of cost/benefit decision making during aging$114,984
R21 · FY2007 · AG · contact PI
Subsecond dopamine release during compulsive drug taking$57,720
R21 · FY2007 · DA · contact PI
Dynamic control of dopamine release in cocaine abuse$74,019
R03 · FY2006 · DA · contact PI
Dynamic control of dopamine release in cocaine abuse$75,800
R03 · FY2005 · DA